Masters of Finance, PACE University, New York. Prior work experience: -24 months as a proprietary trader trading in NYSE and NASDAQ. -14 months as a C++ developer at a Top-20 IT Consulting organization, KPIT Cummins Infosystems Ltd, India. Portfolio Manager: 2004-2007 ~Investing in stocks listed on Indian exchanges. I prefer a top down analysis approach and regularly publish research reports on public companies on Seeking Alpha. Quite a bit of my research is around Natural Gas, specifically gas extracted from Shale which is revolutionizing the energy dynamics in the US.
I have been working in the high-tech industry in various senior leadership roles and have deep interest in financial markets. I received MBA from U-Chicago and pursuing CFA. I have been a management consultant and an individual investor for many years focusing on momentum, spin-offs and IPO strategies. My LinkedIn profile: http://www.linkedin.com/in/jitenderaswani and my business blog can be found here: http://allthingsbusinessanalytics.blogspot.com/
Herve van Caloen, a managing partner at Belpointe Asset Management, is an investor with more than 30 years of experience managing international equity portfolios for Scudder, Mitchell Hutchins, Provident Capital Management. He is currently a portfolio manager at Belpointe Asset Management in Greenwich, CT. He also publishes The Caloen International Report that focuses on international investment topics.
Alan Brochstein, CFA, was the first investment professional to devote himself to sharing his observations about the cannabis industry from an investor's perspective publicly. He runs 420 Investor, a subscription-based due diligence platform for investors interested in the publicly-traded cannabis stocks and is also the founder of New Cannabis Ventures, a content aggregation site focused on investors and entrepreneurs in the cannabis industry.
Alan has worked in the securities industry since 1986, primarily with the responsibility for managing investments in institutional environments until he founded AB Analytical Services in 2007 in order to provide independent research and consulting to registered investment advisors. In addition to advising several different hedge funds and investment managers, including Friedberg Investment Management, where he participated as a member of its investment management committee, Alan was also a senior analyst for the independent research firm Management CV. In 2008, he began providing a first-of-its-kind subscription-based service for individual investors, Invest By Model, which offered two different portfolios that investors could replicate in their own accounts for $20 per month. Alan also offered The Analytical Trader at Marketfy, where he used fundamental and technical analysis in a disciplined process to offer specific trade ideas geared towards swing traders.
Alan launched www.420Investor.com in late 2013 as the premier source of information for "Green Rush" investors seeking to capitalize on the proliferation of legalized medical and recreational cannabis. In March 2014, Alan, who is a member of the National Cannabis Industry Association, began to focus solely on the cannabis sector. He launched www.NewCannabisVentures.com in late 2015.
You can follow Alan on Facebook (www.facebook.com/420investor) or on Twitter (https://twitter.com/Invest420). Alan also moderates a large LinkedIn group focused on the cannabis industry, Cannabis Investors & Entrepreneurs (https://www.linkedin.com/groups/6523904)
Masters of Finance, PACE University, New York.
Prior work experience:
-24 months as a proprietary trader trading in NYSE and NASDAQ.
-14 months as a C++ developer at a Top-20 IT Consulting organization, KPIT Cummins Infosystems Ltd, India.
Portfolio Manager: 2004-2007
~Investing in stocks listed on Indian exchanges.
I prefer a top down analysis approach and regularly publish research reports on public companies on Seeking Alpha. Quite a bit of my research is around Natural Gas, specifically gas extracted from Shale which is revolutionizing the energy dynamics in the US.
Managing Partner & Portfolio Manager
The Rockledge Group
Mr. Alex Gurvich is founding member and a Managing Partner at The Rockledge Group, where he is a Portfolio Manager. Rockledge is an independent investment advisory firm specializing in alternative strategies and sector investing using proprietary “Sector Scoring and Allocation Methodology”. SectorSAM is a robust quantitative sector selection and rotation analysis. Rockledge manages funds for the US and European private and institutional investors.
Mr. Gurvich is a recognized expert in the Exchange Traded Funds space and he is a frequent speaker and panelists in the conferences worldwide. He is also a regular contributor to TheStreet.com ETF Profits website.
Mr. Gurvich is an Adjunct Professor of Finance at Pace University Lubin School of Business. He is a mentor in New York Society of Security Analysts program for the university teams competing in the CFA Institute Research Challenge. Mr. Gurvich serves on the Board of Directors of the New York City Montessori Charter School.
Prior to Rockledge, Mr. Gurvich was a venture capitalist with General Electric’s GE Capital. Prior to GE, Mr. Gurvich started his business career as a management consultant, with Bain & Company. Prior to business school he was an engineer/physicist, with a French high tech scientific instrumentation start up. Prior to this he worked in the medical physics laboratory at the Harvard University.
Mr. Gurvich holds a BA in Physics from the University of Chicago, an MBA from INSEAD, an MS in Financial Engineering from New York University Polytechnic Institute and he is a candidate in the PhD in Financial Engineering program at the Stevens Institute of Technology. He is also a graduate of the Venture Capital Institute.
Marin Katusa, who works with Casey Research (http://www.caseyresearch.com/), is an accomplished investment analyst who specializes in the junior resource sector. He left a successful teaching career to pursue analyzing and investing in junior resource companies. In addition, he is a member of the Vancouver Angel Forum where he and his colleagues evaluate early seed investment opportunities. Marin also manages a portfolio of international real estate projects. Using advanced mathematical skills, he has created a diagnostic resource market tool that analyzes and compares hundreds of investment variables. Through his own investments, Marin has established a network of relationships with many of the key players in the junior resource sector in Vancouver. Marin has the connections, the mathematical and analytical acumen to bring the best investment ideas and most promising Private Placement offerings to Casey Research subscribers.
Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It's designed for easy readability on the site or by email (including on mobile devices), and is published before 7:00 AM ET every market day.
Wall Street Breakfast readership of over 900,000 includes many from the investment-banking and fund-management industries.
Sign up here to receive the Wall Street Breakfast in your inbox every business day: http://seekingalpha.com/account/email_preferences
I am currently a student working on obtaining a Master's degree in Biomedical Sciences, and I have completed a Bachelor's in Biotechnology.
While my background in biotechnology gives me a great perspective into high growth companies, I prefer to focus on equities that are undervalued no matter what sector they fall under. I focus on fundamentals such as Price/Free-Cash-Flow and Price/Book to determine the ideal value of the company and I research management and their prior experience to determine whether to discount or add a premium to the ideal value. I do not use technical data to determine what makes a good investment. Rather, I use it to determine when is the best time to open or close a position in a company that I have determined to be undervalued or overvalued.
Editor for The Biotech Forum, the #2 subscribed to Marketplace investment service offered through SeekingAlpha. Top 5% ranked analyst (TipRanks) 2013 through first half of 2015. Daily contributor for Real Money Pro. Hedge fund manager from 2008 to 2011. Previously technology executive at Fortune 100 firm for a decade.
Please go to biotechforumsa.com for more on the Biotech Forum service available through SeekingAlpha. For Free Investment Reports on a variety of topics go to bretjenseninvests.com
Adam Levine-Weinberg is a graduate student by day, but also follows the stock market obsessively. He is an amateur investor always looking for good value stocks, and generally aims to profit from the market's irrationality.
Stephen Simpson, CFA, is a freelance financial writer and investor.
PLEASE NOTE: As I means of honoring my late wife and grieving her loss, I do not intend to resume writing until mid-July.
I have worked for both sell-side and buy-side firms (equities and fixed income), with the largest percentage of my working time spent in med-tech. At this point I am now effectively in a "working retirement".
I write because I find that the process helps me take better notes, be more disciplined about modeling, and come up with a more coherent investment view for my portfolio management needs. If I'm writing about a stock, it's generally because I'm interested in it as an investment prospect or I think there's an interesting story to tell.
I don't share my models, so please don't ask.
More of my writings can be found at my blog Kratisto Investing (kratistoinvesting.blogspot.com), or Twitter (@Kratisto_Invest).